Insulin and Insulin-like Receptor Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 4774 | BMS 536924 |
| Dual IR/IGF1R inhibitor | |
| 6905 | Ceritinib |
| Potent IR and IGF1R inhibitor; also potently inhibits ALK, STK22D and FLT3 | |
| 5111 | GSK 1838705 |
| Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma kinase (ALK) | |
| 7652 | Linsitinib |
| Potent and selective dual inhibitor of the IGF-1 receptor and insulin receptor | |
| 5247 | NVP ADW 742 |
| ATP-competitive inhibitor of IGF1R | |
| 2956 | Picropodophyllotoxin |
| Selective IGF1R inhibitor | |
| 2768 | PQ 401 |
| IGF1R inhibitor |
Appetite Modulation Scientific Review
Our Peptides Involved in Appetite Modulation review gives an overview of the peptides implicated in appetite regulation and energy homeostasis.
Request copyRequest PDFAngiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF